Ignite Creation Date:
2025-12-25 @ 1:14 AM
Ignite Modification Date:
2026-01-02 @ 1:55 AM
Study NCT ID:
NCT05807893
Status:
COMPLETED
Last Update Posted:
2024-11-13
First Post:
2023-03-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Safety and Efficacy of Serplulimab Plus Bevacizumab and Chemotherapy in NSCLC Patients With Brain Metastases
Sponsor:
Sun Yat-sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-14
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-15
Completion Date Type:
ACTUAL
First Submit Date:
2023-03-13
First Submit QC Date:
None
Study First Post Date:
2023-04-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-10
Last Update Post Date:
2024-11-13
Last Update Post Date Type:
ACTUAL